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have also been shown to be elevated in patients with non-postoperative atrial arrhyth- 
mias, specifically atrial fibrillation (AF). We postulated that a high CRP level would predict 
AF recurrence in patients on antiarrhylhmic drugs (AAD). Methods and results: One hun- 
dred and fifty seven patients who had undergone direct current cardioversion for AF 
between November 2001 and June 2002 were identified (Tablel). All had CRP levels 
drawn prior to the procedure. All these patients had been on AAD prior to and following 
cardioversion. All patients were followed in our out patient clinic.109 patients had recur- 
rence of AF and 48 patients did not have recurrence of AF and responded to AAD. Using 
the Mann-Whitney nonparametric test the mean hsCRP level in the group with recur- 
rence was 0.642 which was statistically higher than the group with no recurrence 0.264 
(p-valuec0.001). Only left ventricular ejection fraction (LVEF) was related to hsCRP in 
multivariate analysis, however LVEF was not statistically different between both groups. 
The odds ratio of developing recurrence was 9 with every 0.5 unit increase over 0.554 (p- 
value<0.001). 
RRR=25%; p=O.57) in DDD-RV, 44% (4/9; RRR=BO%: p&1.13) in DDD-LV and 22% (2/9; 
RRR=75%; p=O.O18) in DDD-BiV. Conclusion: BiVP improves repolarization properties 
as measured by a reduction of TWA, thus contnbuting to the reduction of ventricular 
arrhythmias through this novel mechanism. 
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Conclusion: CRP levels predict recurrence AF in patients on AAD. This may help in risk 
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Wavelet Analysis of Heart Rate Variability Preceding 
Ventricular Arrhvthmias Retrieved From lmolantable 
Cardioverter Dafibrillators in Patients WithMyocardial 
Infarction 
Haran Burri Philippe Chevalier, Mohammad Awl, Paul Rub&, Jocelyne Fayn, Gilbert -3 
Kirkorian, Jean-Yves Le Heuzey, Paul Touboul, H6pital Louis Pradel. Lyon, France, 
H6pital Europ&en Georges Pompidou, Paris, France 
Background: Wavelet transform &VT) is well adapted for analyzing non-stationary sig- 
nals such as heart rate recordings. Changes in autonomic tone leading to ventricular 
arrhythmias may be studied by heart rate variability (HRV). Analysis at different scales by 
Wl can separate High Frequency (HF) from Low-Frequency (LF) signals. Instantaneous 
HF components reflect vagal activity, while LF components are under the influence of 
both sympathetic and parasympathetic tone. Thus, an increased LF/HF ratio may indi- 
cate either increased svmoathetic activitv or decreased vaaal tons. 
Methods: 42 patients (39 males, age 64+8 years) with a history of myocardial infarction 
imolanted with a Biotronik@ Phvlax XM or Microohvlax defibrillator (with an extended 
memory) were included. Each patient required electrical therapy for at least one episode 
of ventricular arrhythmia. RR intervals preceding events were retrieved from the device, 
and HRV studied by WT. 
Results: 117 episodes of ventricular arrhythmia(cycle length 35&22ms) were retrieved. 
LF/HF showed a significant increase dunng the 5 minutes preceding arrhythmia onset. 
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Conclusion: Analysis of HRV by WT shows evidence of increased sympathetic tone or 
parasympathettc withdrawal just before the onset of ventricular arrhythmias. 
1016-8 Does Biventricular Pacing Decrease the Incidence of 
Microvolt T-Wave Alternans? 
Ravmond C. Leunq. Sajad Gulamhusein, Alberta Van Schaik, Katherine Kavanagh, 
University of Alberta, Edmonton, AB, Canada 
Background: Biventricular pacing (BiVP) improves symptoms and hemodynamics in 
heart failure patients with ventricular conduction delay. Controversy exists as to why a 
significant reduction of ventricular arrhythmia was observed in patients with BiVP. Pres- 
ence of microvolt T-wave alternans (TWA) during rapid atrial pacing is independently 
predictive of ventricular arrhythmic events. We hypothesize that BiVP reduces ventricular 
arrhythmias by repolarization resynchronization as measured by a reduction of TWA. 
Methods: Patients (n=13) with permanent BiVP were studled. TWA were measured by 
spectral method using Heartwave system (Cambridge Heart) at rapid atrial (AAI) and var- 
ious ventricular (DDD) pacing modes. TWA were interpreted by standard protocol. 
Results: Four patients were excluded due to AV block at cl05 bpm. The results of the 
remaining 9 patients are shown below. In AAI pacing, 8 of the 9 patients (89%) have pos- 
itive TWA. Comparatively, frequency of positive TWA was reduced to 67% (619; 
1016-g Infarct Morphology Identifies Patients With Substrate 
for Ventricular Tachycardia 
David Belle David S. Fieno. F. Scott Per&s, Gina K. Song, Andrea Wesson, Rod -I 
Passman, Alan Kadish, Jeffrey Goldberger, Northwestern University Feinberg School of 
Medicine, Chicago, IL 
To evaluate whether infarct morphology identifies patients (pts) with substrate for induc- 
ible monomorphic ventricular tachycardia (MVT), 48 pts (age 6Oill years, 56% male) 
with coronary artery disease undergoing electrophysiologic studies (EPS) had tine and 
contrast-enhanced (gadolinium) MRI. Planimetry of the contrast images was used to 
measure infarct mass and surface area by two readers blinded to EPS results. 
Results: 21 (44%) pts had no inducible ventricular arrhythmias (No VT). 18 (37%) pts had 
inducible MVT, cycle length 273+49 ms, and 9 (19%) pts had inducible polymorphic VT 
or ventricular fibrillation (PVTNF). Table shows MRI results (in table, * = P&lt;0.005 vs 
No VT). There were no differences in ejection fraction (EF) among the three groups, but 
pts with MVT had larger infarcts. By linear regression, infarct size correlates negatively 
with EF (R2 0.21 to 0.27, p&lt:O.OOl). Infarct size was a better discriminant of inducible 
MVT than EF. The findtngs for PVTNF wars intermediate between those for No VT and 
MVT, consistent with the nonspecific nature of this induced arrhythmia. Transmural inf- 
arct, aneurysms, and infarct location did not discriminate between pts with inducible MVT 
and pts with No VT. 
MRI Findings 
Infarct mass Infarct mass as % Of Infarct Surface Area EF (%) 
(9) LV (mm2) 
NOVT 2&5 14*3 9289*1403 35*3 
MVT 49*5 26i3 * 17201+1531 * 28+2 
PVTNF 36+7 20*3 11482+2210 * 34+6 
Conclusion: Infarct size is a better identifier of patients who have MVT than EF. As all 
current clinically used risk stratification strategies are based on EF, further evaluation of 
infarct morphology characterization by cardiac MRI is warranted. 
1016-10 Frequency of Implantable Cardioverter Fibrillator 
Discharges in New York Following the World Trade 
Center Attack 
Avsha Arshad. Marcin Kowalski. Atul Kukar, Valentin Suma, Margot E. Vloka, Frederick 
A. Ehlert, Bengt Herweg, Jacqueline E. Donnelly, Julie Philip, George Reed, Alan 
Rozanski, Jonathan S. Steinberg, St. Luke’s_Roosevelt Hospital Center and Columbia 
University College of Physicians and Surgeons, New York, NY, University of 
Massachusetts Medical School, Worcester, MA 
Background: We have recently described an increase in the ICD discharge rate of pati- 
etns in the New York metropolitan area following the World Trade Center (WTC) attack 
on 9/l l/01. In our cohort of 200 patients there was a 2.3-fold increase in risk in the 30 
days after 9/l 1 versus the 30 days before. We sought to evaluate the ICD discharge rate 
in this population over an 8 month observation period and to detenine when the 
increased rate of discharges returned to pre 9/l 1 levels. 
Methods: To determine the pattern of daily arrhythmic events from 5/l l/O1 to l/10/02, 
triggering ICD discharges over the 8 month time period, a logistic model and a general- 
ized estimating equation approach to account for within subject correlation were 
employed. 
Results: The incidence of ICD activation for ventricular tachvarrhvthmias for Mav , , 
through July 2001 was 2.1-4.4% and for October through December 2001 was 2.2.3.2%, 
versus 8% for Seotember 2001. Looistic rearession model identified the 30 dav oeriod _ _ , 
following 9/l 1 as statistically different (p=O.O038) than the other 30 day intervals. (see 
figure) 
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Conclusion: There is a clear-cut increment in life threatening ventricular tachyarrhyth- 
mia incidence in ICD patients in weeks after 9/l 1 with a return to baseline after approxi- 
mately 30 days. 
(n=50, 19% of total), a cause of SCD remained uncertain in only 36% (~~0.05 vs VW). 
CAD accounted for 13 cases. No patient (YW or VU) received an implantable defibrilla- 
tor. 
Conclusions: In women age 20-34 years, there was an unexpectedly high rate of unex- 
plained SCD compared to man (56% vs 36%; peO.05). A prospective, population-based 
evaluation of SCD in this age group is warranted. 
1016-11 Antecedent Hypertension Predisposes to Arrhythmic 
Death After Acute Myocardial Infarction: An Insight 
From Contemporary Survival Studies 
Yee Guan Yap, Trinh Duong. Martin Bland, Christian Tarp-Pederson, Lars Kober, Marek 
Malik, Stuart Connolly, Bradley Marchant, A. John Camm, St. George’s Hospital Medical 
School, London, United Kingdom 
Background: Arrhythmic death (AD) is the commonest mode of death after acute myo- 
cardial infarction (AMI) but the role of antecedent hypertension (AH) on the risk of 
arrhythmic death after AMI is unknown. Methods: We pooled the individual data on 3105 
placebo patient (247lM, median age: 65 (23-92)) from E.M.I.A.T.. C.A.M.I.A.T., 
S.W.O.R.D., T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. with LVEF<40% or frequent ventricular 
ectopics. Survival was measured from day 45 after Ml to allow for different recruitment 
periods. Cox multiple regression was used. Results: There were 466 deaths by 2 years 
(220 AD & 172 non-arrhythmic cardiac death (NAD)). After adjusted for significant vari- 
ables associated with either AD or NAD (age, previous MI. gender, angina, systolic blood 
pressure, heart rate, NYHA class, LVEF & Q-wave). patients with AH had a significantly 
higher ratio of AD to NAD at 2 years after the index infarct, but not in patients without AH. 
Cause-specific P-year incidence (AD:NAD, %): AH= 11 .O : 6.4: no AH= 7.7 : 7.2. Ratio of 
relative hazard of AD:NAD (95% Cl): AH= 1.65 (1.02-2.65); no AH=l, p= 0.04. The inter- 
action between AH and AD versus NAD is even greater when measuring from the time of 
index infarct in T.R.A.C.E. and D.I.A.M.O.N.D.-M.I. patients only (p= 0.006). Conclu- 
sion: Our study provides the first data that AH predisposes to AD at 24 months after 
AMI. Such data is vital in refining the risk stratification of high risk patients similar to those 
of MADIT II patients for expensive implantable defibrillator therapy 
1016-12 Sex Selection in Unexplained Sudden Cardiac Death 
Kivon Chunq, Benjamin John, Vivek Dogra. Zhi-Jie Zheng, JackTitus, Sumeet S. Chugh. 
Oregon Health & Science University, Portland, OR, Jesse E. Edwards Registry of 
Cardiovascular Disease, St. Paul. MN 
Background: The US Centers for Disease Control and Prevention recently reported a dis- 
proporiionate increase in sudden cardiac death (SCD) in the youngest US women YS 
man (32% vs 10%; age group 15-34 y) during 1969-1996. 
Methods: Due to under-representation of this age group in existing autopsy series, we 
explored the etiologies of SCD in US women (VW) and men (YM) age 20-34 yrs from a 
13-year (1964.1996) autopsy series of SCD. All consecutive cases of SCD referred to 
the JE Edwards Registry from a US 3-county area ware analyzed. Autopsy reports were 
examined, archived hearts subjected to detailed gross/histologic examination and corra- 
lation made with clinical history, toxicologic screen 8 circumstances of death. 
Results: Of 270 total cases (age X20 yrs), YW constituted 14% (n=39). A definitive cause 
of SCD could not be determined in 22 (56%). Findings in other patients included myo- 
carditis (n=4), arrhythmogenic right ventricular dysplasia (n=3), congenital heart disease 
(n=2). coronary artery disease (CAD, n=2), and coronary artery anomalies (n=2). In YM 
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1017-l Prevention of Atrial Fibrillation by Atrial Overdrive 
Pacing: Final Results of a Randomized Crossover Study 
Karl-Heinz Kon~ Johannes Brachmann, Patrick Attuel, Dia El Allaf. Candid0 Games. 
lstvan Szendey, Volker Schibgilla, Dejan Danilovic, Maria Hilf Clinics, 
Moenchengladbach, Germany, Coburg Clinics, &burg, Germany 
Background: Dynamic atrial overdrive at a rate slightly above the intrinsic rate may sup- 
press recurrences of atrial tachyarrhythmia (AT) in pacemaker patients (pts). We evalu- 
ated clinical efficacy of the DDD+ overdrive mode in dual chamber Inos2 CLS 
pacemakers (Biotronik, Germany). 
Methods: 100 pts with paroxysmal AT and conventional pacing indications (71% sinus 
node disease, 25% atrioventricular block) were randomized to DDD+ or DDD mode at 3 
months after pacemaker implantation. A bipolar atrial lead was placed in the right 
appendage (60%) or laterally (40%). The basic rate was programmed to 61.5 r 4.3 
beatslmin (bpm). Upon sensing an atrial event, the DDD+ mode increased the pacing 
rate by 6 + 2 bpm. followed by 1 bpm rate decrease after each 20 * 3 atrial beats. The 
modes were crossed 6 months after randomization, and the pts were followed for 6 
months in the other mode. The cumulative duration of sustained (> 60 s) AT episodes 
was extracted from the pacemaker memory and compared for the two modes on intrapa- 
tient basis (paired two-tailed t-test). The comparison was made for the entire study popu- 
lation and for different subgroups of pts, in order to evaluate clinical predictors of the 
overdrive therapy outcome. 
Results: Crossover data ware collected in 75 pts; the remaining 25 pts were drop-outs. 
The AT burden was reduced by 26%, from 16.3 (DDD) to 12.0 hours/week (DDD+, p = 
0.066). In 32 pts with AT burden >2% of time (30 miniday), the reduction was 26%, from 
37.6 (DDD) to 27.0 h/week (DDD+, p = 0.044). The subgroups of pts with the most signif- 
icant reduction in AT burden were: 50 pts with < 60% of atrial pacing in DDD mode: 16.1 
(DDD) vs 6.6 h/week (DDD+, 45% reduction, p = 0.016), 25 pts with the basic rate sat to 
65-75 bpm: 29.0 (DDD) vs 16.6 h/week (DDD+, 43% reduction, p = O.Oll), and 34 pts 
who did not take beta-blocker drugs: 16.0 (DDD) vs 7.1 h/week (DDD+, 55% reduction, p 
= 0.026). In the complementary groups to these 3 subgroups there was no additional 
benefit of DDD+ over DDD pacing (O-l 1% reduction in AT burden, p > 0.57). 
Conclusion: DDD+ overdrive pacing exerted the strongest antiarrhythmic effect in pts 
paced less than 60% of time in the DDD mode, in pts with basic rate set to 65-75 bpm, 
and in pts taking no beta-blocker drugs. 
1017-2 Impact of Prevention Pacing Algorithms on Atrlal 
Tachyarrhythmia Recurrence Patterns in Patients 
Suffering From Brady-Tachy Form of Sick Sinus 
Syndrome: A Randomized Study 
Renato Ricci, Luiai Padeletti Gian Luca B&o, Giuseppe Boriani. Stefano Favale, 
Andrea Spampinato, Alessandro Capucci, Michele Gulizia. Paolo Rizzon, Pa& 
Pieragnoli, Marco Vimercati. Andrea Grammatico. Massimo Santini. San Filippo Neri 
Hospital, Rome, Italy 
Background. Preventive atrial pacing may reduce the incidence of atrial fibrillation (AF). 
either by eliminating the triggers and/or by modifying the substrate of the arrhythmia, but 
convincing results about prevention pacing impact from randomized and controlled stud- 
ies are still missing. 
Aim. A prospective, randomized multicentric study has been designed to measure prs- 
vention algorithms impact on AF burden, AF frequency and new endpoints, based on the 
number of sinus rhythm (SR) and AF days, in patients suffering from the brady-tachy 
foml of sick sinus syndrome. 
Methods.108 patients (age 72.3e2.7 years; 52.6% male) from 15 centers wars implanted 
with a DDDRP pacing system (Model AT500, Medtronic, Inc.) including three prevention 
pacing algorithms (Prev). Patients were randomized one-month post implant to DDDR or 
DDDR+Prev for 3 months and then crossed over for additional 3 months. 
Results, by using pacemaker diagnostics, were as follows: 
